基于牙槽突裂体积的失败率:牙槽骨移植临界尺寸缺损分析
回顾性分析2016至2022年93例牙槽骨移植患者,比较髂骨骨移植(ICBG,n=30)与rhBMP-2/脱钙骨基质(DBM,n=63)的移植失败率,用术前锥形束CT计算缺损体积。ICBG和rhBMP-2/DBM的临界尺寸缺损分别为810 mm³和885 mm³,超过临界值后失败率显著升高。
要点
- ICBG临界尺寸缺损为810 mm³,超过者失败率71.4% vs 未超过者0.0%(P<0.001)。
- rhBMP-2/DBM临界尺寸缺损为885 mm³,超过者失败率65.0% vs 未超过者14.0%(P<0.001)。
- 牙槽突裂体积可用于指导ICBG或rhBMP-2/DBM的移植选择。
核心结论
- 本研究基于牙槽突裂体积确定了ICBG和rhBMP-2/DBM的临界尺寸缺损,超过预测阈值的移植失败率更高。
- 研究识别出不同的牙槽突裂体积范围,患者可能从各自的移植选择中获益。
研究设计与样本
- 回顾性综述,评估2016年至2022年接受牙槽骨移植的患者。
- 纳入标准为具备术前和术后锥形束CT(CBCT)影像的患者,共纳入93例。
- 骨移植队列包括ICBG(n=30)和rhBMP-2/DBM(n=63),采用术前影像计算体积缺损大小。
- 移植成功标准基于临床和影像学结果,采用逻辑回归分析移植失败率以确定最佳截断值,定义临界尺寸缺损。
主要发现
- ICBG的临界尺寸缺损计算为810 mm³,rhBMP-2/DBM为885 mm³。
- ICBG超过临界尺寸者移植失败率为71.4%,未超过者为0.0%(P<0.001)。
- rhBMP-2/DBM超过临界尺寸者移植失败率为65.0%,未超过者为14.0%(P<0.001)。
关键数值与推荐
- ICBG临界尺寸缺损:810 mm³。
- rhBMP-2/DBM临界尺寸缺损:885 mm³。
- ICBG超过临界尺寸者失败率71.4% vs 未超过者0.0%(P<0.001)。
- rhBMP-2/DBM超过临界尺寸者失败率65.0% vs 未超过者14.0%(P<0.001)。
临床怎么用
- 作者认为,牙槽突裂体积可用于指导外科医生选择ICBG或rhBMP-2/DBM进行牙槽骨移植。
- 作者指出,超过预测临界尺寸的移植失败率更高,不同牙槽突裂体积范围的患者可能从各自的移植选择中获益。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Alveolar bone grafting (ABG) using iliac crest bone graft (ICBG) is the best practice for children with complete cleft lip and palate. With the advent of recombinant human bone morphogenetic protein (rhBMP-2) and demineralized bone matrix (DBM), excellent results can be achieved while avoiding donor-site morbidity. This study aimed to determine critical-size defects by analyzing graft failure rates for ICBG and rhBMP-2/DBM to guide surgeons performing ABG. METHODS: A retrospective review was conducted evaluating patients who underwent ABG from 2016 through 2022. Patients with preoperative and postoperative cone beam computed tomography (CBCT) imaging were included. Volumetric defect sizes were calculated using preoperative imaging. Graft success criteria were based on both clinical and radiographic outcomes. Logistic regressions analyzed graft failure rates to identify an optimal cutoff, which defined the critical-size defect. RESULTS: A total of 93 patients were included. Bone graft cohorts included ICBG ( n = 30) and rhBMP-2/DBM ( n = 63). The critical-size defects were calculated to be 810 mm 3 and 885 mm 3 for ICBG and rhBMP-2/DBM, respectively. There were significantly higher graft failure rates beyond the critical size compared with below for both ICBG (71.4% versus 0.0%; P < 0.001) and rhBMP-2/DBM (65.0% versus 14.0%; P < 0.001). CONCLUSIONS: This study identified critical-size defects based on alveolar cleft volume for ICBG or rhBMP-2/DBM with higher graft failure rates beyond the predicted thresholds. Distinct ranges in cleft volume were identified where patients might benefit from each select graft option. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
引用
- Roohani I, Youn S, Alfeerawi S, et al. Failure Rates Based on Alveolar Cleft Volume: Analysis of the Critical-Size Defect for Alveolar Bone Grafting. Plast Reconstr Surg. 2024. PMID: 38684030. doi:10.1097/PRS.0000000000011503
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。